Literature DB >> 7935378

An interaction between the DNA-binding domains of RelA(p65) and Sp1 mediates human immunodeficiency virus gene activation.

N D Perkins1, A B Agranoff, E Pascal, G J Nabel.   

Abstract

Induction of human immunodeficiency virus type 1 (HIV-1) gene expression in stimulated T cells has been attributed to the activation of the transcription factor NF-kappa B. The twice-repeated kappa B sites within the HIV-1 long terminal repeat are in close proximity to three binding sites for Sp1. We have previously shown that a cooperative interaction of NF-kappa B with Sp1 is required for the efficient stimulation of HIV-1 transcription. In this report, we define the domains of each protein responsible for this effect. Although the transactivation domains seemed likely to mediate this interaction, we find, surprisingly, that this interaction occurs through the putative DNA-binding domains of both proteins. Sp1 specifically interacted with the amino-terminal region of RelA(p65). Similarly, RelA bound directly to the zinc finger region of Sp1. This interaction was specific and resulted in cooperative DNA binding to the kappa B and Sp1 sites in the HIV-1 long terminal repeat. Furthermore, the amino-terminal region of RelA did not associate with several other transcription factors, including MyoD, E12, or Kox15, another zinc finger protein. These findings suggest that the juxtaposition of DNA-binding sites promotes a specific protein interaction between the DNA-binding regions of these transcription factors. This interaction is required for HIV transcriptional activation and may provide a mechanism to allow for selective activation of kappa B-regulated genes.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7935378      PMCID: PMC359187          DOI: 10.1128/mcb.14.10.6570-6583.1994

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  78 in total

1.  Contribution of NF-kappa B and Sp1 binding motifs to the replicative capacity of human immunodeficiency virus type 1: distinct patterns of viral growth are determined by T-cell types.

Authors:  E K Ross; A J Buckler-White; A B Rabson; G Englund; M A Martin
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

2.  Cloning of an NF-kappa B subunit which stimulates HIV transcription in synergy with p65.

Authors:  R M Schmid; N D Perkins; C S Duckett; P C Andrews; G J Nabel
Journal:  Nature       Date:  1991-08-22       Impact factor: 49.962

3.  The rel-associated pp40 protein prevents DNA binding of Rel and NF-kappa B: relationship with I kappa B beta and regulation by phosphorylation.

Authors:  L D Kerr; J Inoue; N Davis; E Link; P A Baeuerle; H R Bose; I M Verma
Journal:  Genes Dev       Date:  1991-08       Impact factor: 11.361

4.  vRel is an inactive member of the Rel family of transcriptional activating proteins.

Authors:  P M Richardson; T D Gilmore
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

5.  Structural characteristics of the 5' region of the human ICAM-1 gene.

Authors:  B G Stade; G Messer; G Riethmüller; J P Johnson
Journal:  Immunobiology       Date:  1990-12       Impact factor: 3.144

6.  Association between proto-oncoprotein Rel and TATA-binding protein mediates transcriptional activation by NF-kappa B.

Authors:  L D Kerr; L J Ransone; P Wamsley; M J Schmitt; T G Boyer; Q Zhou; A J Berk; I M Verma
Journal:  Nature       Date:  1993-09-30       Impact factor: 49.962

7.  Functional interaction of the v-Rel and c-Rel oncoproteins with the TATA-binding protein and association with transcription factor IIB.

Authors:  X Xu; C Prorock; H Ishikawa; E Maldonado; Y Ito; C Gélinas
Journal:  Mol Cell Biol       Date:  1993-11       Impact factor: 4.272

8.  NF-kappa B contacts DNA by a heterodimer of the p50 and p65 subunit.

Authors:  M B Urban; R Schreck; P A Baeuerle
Journal:  EMBO J       Date:  1991-07       Impact factor: 11.598

9.  Inhibition of transcription factors belonging to the rel/NF-kappa B family by a transdominant negative mutant.

Authors:  F Logeat; N Israël; R Ten; V Blank; O Le Bail; P Kourilsky; A Israël
Journal:  EMBO J       Date:  1991-07       Impact factor: 11.598

10.  A cooperative interaction between NF-kappa B and Sp1 is required for HIV-1 enhancer activation.

Authors:  N D Perkins; N L Edwards; C S Duckett; A B Agranoff; R M Schmid; G J Nabel
Journal:  EMBO J       Date:  1993-09       Impact factor: 11.598

View more
  83 in total

1.  The von Hippel-Lindau tumor suppressor gene product interacts with Sp1 to repress vascular endothelial growth factor promoter activity.

Authors:  D Mukhopadhyay; B Knebelmann; H T Cohen; S Ananth; V P Sukhatme
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

2.  Promoter selective transcriptional synergy mediated by sterol regulatory element binding protein and Sp1: a critical role for the Btd domain of Sp1.

Authors:  J N Athanikar; H B Sanchez; T F Osborne
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

Review 3.  Regulation of HIV-1 transcription.

Authors:  K A Roebuck; M Saifuddin
Journal:  Gene Expr       Date:  1999

4.  A new member of the I kappaB protein family, I kappaB epsilon, inhibits RelA (p65)-mediated NF-kappaB transcription.

Authors:  Z Li; G J Nabel
Journal:  Mol Cell Biol       Date:  1997-10       Impact factor: 4.272

5.  Involvement of TFIID and USA components in transcriptional activation of the human immunodeficiency virus promoter by NF-kappaB and Sp1.

Authors:  M Guermah; S Malik; R G Roeder
Journal:  Mol Cell Biol       Date:  1998-06       Impact factor: 4.272

6.  Altered DNA-binding specificity mutants of EKLF and Sp1 show that EKLF is an activator of the beta-globin locus control region in vivo.

Authors:  N Gillemans; R Tewari; F Lindeboom; R Rottier; T de Wit; M Wijgerde; F Grosveld; S Philipsen
Journal:  Genes Dev       Date:  1998-09-15       Impact factor: 11.361

7.  Coexpression of NF-kappa B/Rel and Sp1 transcription factors in human immunodeficiency virus 1-induced, dendritic cell-T-cell syncytia.

Authors:  A Granelli-Piperno; M Pope; K Inaba; R M Steinman
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-21       Impact factor: 11.205

8.  Domains of transcription factor Sp1 required for synergistic activation with sterol regulatory element binding protein 1 of low density lipoprotein receptor promoter.

Authors:  L Yieh; H B Sanchez; T F Osborne
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-20       Impact factor: 11.205

9.  Functional Incompatibility between the Generic NF-κB Motif and a Subtype-Specific Sp1III Element Drives the Formation of the HIV-1 Subtype C Viral Promoter.

Authors:  Anjali Verma; Pavithra Rajagopalan; Rishikesh Lotke; Rebu Varghese; Deepak Selvam; Tapas K Kundu; Udaykumar Ranga
Journal:  J Virol       Date:  2016-07-27       Impact factor: 5.103

10.  LMP1-augmented kappa intron enhancer activity contributes to upregulation expression of Ig kappa light chain via NF-kappaB and AP-1 pathways in nasopharyngeal carcinoma cells.

Authors:  HaiDan Liu; Hui Zheng; Zhi Duan; DuoSha Hu; Ming Li; SuFang Liu; ZiJian Li; XiYun Deng; ZhenLian Wang; Min Tang; Ying Shi; Wei Yi; Ya Cao
Journal:  Mol Cancer       Date:  2009-10-27       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.